Media Center
More than 3,600 participants from around the world open new opportunities for Slovenia’s breakthrough pharmaceutical and biotechnology industries
More
Today marks an important milestone for the Slovenia Biotech Hills Institute.
MoreIn today’s pharmaceutical industry, it is increasingly clear that time is the most valuable currency. “Time-to-market” is becoming a key indicator of competitive advantage, as companies face growing pressure to develop therapies for increasingly complex medical needs. In an environment where the average development of a new drug takes more than a decade and requires multi-billion investments, every process optimization has a direct impact not only on business performance but also on patient health worldwide.
More
The European Commission has established a new center for biotechnology and biomanufacturing with the aim of supporting companies in introducing their innovative products to the EU market and increasing their competitiveness. The Biotechnology and Biomanufacturing Hub is a key outcome of the Commission’s strategy to promote biotechnology and biomanufacturing in the EU.
More
The government has signed a letter of intent with the Biotech Hills institute, a newly-established business accelerator in biotechnology. The partnership seeks to make Slovenia the most attractive destination in Europe for R&D, manufacturing and investment in biotechnology and pharmaceuticals.
More
La Slovenia punta a diventare un polo di attrazione a livello regionale per le biotecnologie.
More